The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells
Open accessAbstract
Background: Translational control mediated by non-coding microRNAs (miRNAs) plays a key role in the mechanism of cellular resistance to anti-cancer drug treatment. Dihydrofolate reductase (DHFR) and thymidylate synthase (TYMS, TS) are two of the most important targets for antifolate- and fluoropyrimidine-based chemotherapies in the past 50 years. In this study, we investigated the roles of miR-215 in the chemoresistance to DHFR inhibitor methotrexate (MTX) and TS inhibitor Tomudex (TDX). Results: The protein levels of both DHFR and TS were suppressed by miR-215 without the alteration of the target mRNA transcript levels. Interestingly, despite the down-regulation of DHFR and TS proteins, ectopic expression of miR-215 resulted in a decreased sensitivity to MTX and TDX. Paradoxically, gene-specific small-interfering RNAs (siRNAs) against DHFR or TS had the opposite effect, increasing sensitivity to MTX and TDX. Further studies revealed that over-expression of miR-215 inhibited cell proliferation and triggered cell cycle arrest at G2 phase, and that this effect was accompanied by a p53-dependent up-regulation of p21. The inhibitory effect on cell proliferation was more pronounced in cell lines containing wild-type p53, but was not seen in cells transfected with siRNAs against DHFR or TS. Moreover, denticleless protein homolog (DTL), a cell cycle-regulated nuclear and centrosome protein, was confirmed to be one of the critical targets of miR-215, and knock-down of DTL by siRNA resulted in enhanced G2-arrest, p53 and p21 induction, and reduced cell proliferation. Additionally, cells subjected to siRNA against DTL exhibited increased chemoresistance to MTX and TDX. Endogenous miR-215 was elevated about 3-fold in CD133+HI/CD44+HI colon cancer stem cells that exhibit slow proliferating rate and chemoresistance compared to control bulk CD133+/CD44+ colon cancer cells. Conclusions: Taken together, our results indicate that miR-215, through the suppression of DTL expression, induces a decreased cell proliferation by causing G2-arrest, thereby leading to an increase in chemoresistance to MTX and TDX. The findings of this study suggest that miR-215 may play a significant role in the mechanism of tumor chemoresistance and it may have a unique potential as a novel biomarker candidate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14
Lee, R. C., Feinbaum, R. L., & Ambros, V. (1993) · Cell · doi:10.1016/0092-8674(93)90529-y · Cited by 12,948
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
Identification and expansion of human colon-cancer-initiating cells
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & De Maria, R. (2007) · Nature · doi:10.1038/nature05384 · Cited by 3,998
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis
Chang, T.-C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.010 · Cited by 2,010 · cited 1×
“Previous study from our laboratory has shown a number of miRNAs may be directly regulated by tumor suppressor gene p53 [19], and this novel mechanism has been proved to be critical as part of the p53 function in regulating cell cycle and proliferation [20-24].”
BackgroundRegulation of the G2/M transition by p53
Taylor, W. R., & Stark, G. R. (2001) · Oncogene · doi:10.1038/sj.onc.1204252 · Cited by 1,559
Transcriptional Activation of miR-34a Contributes to p53-Mediated Apoptosis
Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N., Bentwich, Z., & Oren, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.017 · Cited by 1,352
MicroRNA-Cancer Connection: The Beginning of a New Tale
Calin, G. A., & Croce, C. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0800 · Cited by 1,053
Meng, F., Henson, R., Lang, M., Wehbe, H., Maheshwari, S., Mendell, J. T., Jiang, J., Schmittgen, T. D., & Patel, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.057 · Cited by 984
Shmelkov, S. V., Butler, J. M., Hooper, A. T., Hormigo, A., Kushner, J., Milde, T., St. Clair, R., Baljevic, M., White, I., Jin, D. K., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34401 · Cited by 896
Salonga, D. S., Danenberg, K. D., Johnson, M. R., Metzger, R., Groshen, S. G., Tsao-Wei, D. D., Lenz, H.-J., Leichman, C. G., Leichman, L., Diasio, R. B., et al. (2000) · PubMed · Cited by 829
THE CATALYTIC MECHANISM AND STRUCTURE OF THYMIDYLATE SYNTHASE
Carreras, C. W., & Santi, D. V. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.003445 · Cited by 768
CD44 is of Functional Importance for Colorectal Cancer Stem Cells
Du, L., Wang, H., He, L., Zhang, J., Ni, B., Wang, X., Jin, H., Cahuzac, N., Mehrpour, M., Lu, Y., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1034 · Cited by 588
p53 Regulates Hematopoietic Stem Cell Quiescence
Liu, Y., Elf, S. E., Miyata, Y., Sashida, G., Liu, Y., Huang, G., Di Giandomenico, S., Lee, J. M., Deblasio, A., Menendez, S., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2008.11.006 · Cited by 547
p53-Responsive MicroRNAs 192 and 215 Are Capable of Inducing Cell Cycle Arrest
Braun, C. J., Zhang, X., Savelyeva, I., Wolff, S., Moll, U. M., Schepeler, T., Ørntoft, T. F., Andersen, C. L., & Dobbelstein, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1569 · Cited by 473
Principles and effects of microRNA-mediated post-transcriptional gene regulation
Engels, B. M., & Hutvagner, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209909 · Cited by 409
Autoregulation of human thymidylate synthase messenger RNA translation by thymidylate synthase.
Chu, E., Koeller, D. M., Casey, J. L., Drake, J. C., Chabner, B. A., Elwood, P. C., Zinn, S., & Allegra, C. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.8977 · Cited by 382
Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215
Georges, S. A., Biery, M. C., Kim, S.-Y., Schelter, J. M., Guo, J., Chang, A. N., Jackson, A. L., Carleton, M. O., Linsley, P. S., Cleary, M. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1846 · Cited by 348
The Guardian's Little Helper: MicroRNAs in the p53 Tumor Suppressor Network
He, X., He, L., & Hannon, G. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2672 · Cited by 317
Prognostic Values of microRNAs in Colorectal Cancer.
Xi, Y., Formentini, A., Chien, M., Weir, D. B., Russo, J. J., Ju, J., Kornmann, M., & Ju, J. (2006) · PubMed Central · Cited by 293
Self-citationNovel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase
Banerjee, D., Mayer-Kuckuk, P., Capiaux, G., Budak-Alpdogan, T., Gorlick, R., & Bertino, J. R. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(02)00079-0 · Cited by 242
Xi, Y., Shalgi, R., Fodstad, O., Pilpel, Y., & Ju, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1853 · Cited by 212
Self-citationThe pharmacology of methotrexate
Olsen, E. A. (1991) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(91)70199-c · Cited by 192
Higa, L. A., Banks, D., Wu, M., Kobayashi, R., Sun, H., & Zhang, H. (2006) · Cell Cycle · doi:10.4161/cc.5.15.3149 · Cited by 179
DTL/CDT2 is essential for both CDT1 regulation and the early G2/M checkpoint
Sansam, C. L., Shepard, J. L., Lai, K., Ianari, A., Danielian, P. S., Amsterdam, A., Hopkins, N., & Lees, J. A. (2006) · Genes & Development · doi:10.1101/gad.1482106 · Cited by 171
The reversal of methotrexate cytotoxicity to mouse bone marrow cells by leucovorin and nucleosides.
Pinedo, H. M., Zaharko, D. S., Bull, J. M., & Chabner, B. A. (1976) · PubMed · Cited by 164
Song, B., Wang, Y., Kudo, K., Gavin, E. J., Xi, Y., & Ju, J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1422 · Cited by 150
Self-citationvan Triest, B., Pinedo, H. M., van Hensbergen, Y., Smid, K., Telleman, F., Schoenmakers, P. S., van der Wilt, C. L., van Laar, J. A. M., Noordhuis, P., Jansen, G., et al. (1999) · PubMed · Cited by 145
Regulation of translation initiation following stress
Sheikh, M. S., & Fornace, A. J. (1999) · Oncogene · doi:10.1038/sj.onc.1203131 · Cited by 140
Translational regulation of human p53 gene expression.
Fu, L., Minden, M. D., & Benchimol, S. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00812.x · Cited by 138
Banks, D., Wu, M., Higa, L. A., Gavrilova, N., Quan, J., Ye, T., Kobayashi, R., Sun, H., & Zhang, H. (2006) · Cell Cycle · doi:10.4161/cc.5.15.3150 · Cited by 127
MicroRNA-Cancer Connection: The Beginning of a New Tale
Calin, G. A., & Croce, C. M. (2008) · AACR Education book · doi:10.1158/aacr.edb-can-06-0800 · Cited by 120
Regulation of p53 expression by thymidylate synthase
Ju, J., Pedersen-Lane, J., Maley, F., & Chu, E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3769 · Cited by 117
Self-citationPhenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
Botchkina, I. L., Rowehl, R. A., Rivadeneira, D. E., Karpeh, M. S., Crawford, H. C., Dufour, A., Ju, J., Wang, Y., Leyfman, Y., & Botchkina, G. I. (2009) · PubMed · Cited by 107
Self-citationShowalter, S. L., Showalter, T. N., Witkiewicz, A., Havens, R., Kennedy, E. P., Hucl, T., Kern, S. E., Yeo, C. J., & Brody, J. R. (2008) · Cancer Biology & Therapy · doi:10.4161/cbt.7.7.6181 · Cited by 104
Thymidylate Synthase Protein and p53 mRNA Form an In Vivo Ribonucleoprotein Complex
Chu, E., Copur, S. M., Ju, J., Chen, T.-M., Khleif, S. N., Voeller, D. M., Mizunuma, N., Patel, M. C., Maley, G. F., Maley, F., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.2.1582 · Cited by 101
Self-citationUeki, T., Nishidate, T., Park, J. H., Lin, M., Shimo, A., Hirata, K., Nakamura, Y., & Katagiri, T. (2008) · Oncogene · doi:10.1038/onc.2008.186 · Cited by 95
Pan, H., Chou, H.-Y. E., Liu, S.-H., Peng, S., Liu, C.-L., & Hsu, H. (2006) · Cell Cycle · doi:10.4161/cc.5.22.3500 · Cited by 84
Johnston, P. G., Benson, A. B., Catalano, P. J., Rao, M. S., O'Dwyer, P. J., & Allegra, C. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.039 · Cited by 82
Small is beautiful: microRNAs and breast cancer—where are we now?
Verghese, E. T., Hanby, A., Speirs, V., & Hughes, T. A. (2008) · The Journal of Pathology · doi:10.1002/path.2359 · Cited by 72
Cancer initiating cells or cancer stem cells in the gastrointestinal tract and liver
Zou, G.-M. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21541 · Cited by 62
Li, J., Ng, E. K. O., Ng, Y. P., Wong, C. Y., Yu, J. Q., Jin, H., Cheng, V. Y. Y., Go, M. Y. Y., Cheung, P. K. F., Ebert, M. P. A., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605202 · Cited by 56
Kozak, M. (2008) · Gene · doi:10.1016/j.gene.2008.07.013 · Cited by 47
Wang, W., McLeod, H. L., Cassidy, J., & Collie-Duguid, E. S. R. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0384-5 · Cited by 45
Schmitz, J. C., Chen, T.-M., & Chu, E. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1203 · Cited by 40
Peters, G. J., Smitskamp-Wilms, E., Smid, K., Pinedo, H. M., & Jansen, G. (1999) · PubMed · Cited by 29
Xi, Y., Edwards, J. R., & Ju, J. (2007) · PubMed Central · Cited by 21
Self-citationCell-Cycle-Dependent Pharmacology of Methotrexate in HL-60
Yamauchi, A., Ichimiya, T., Inoue, K., Taguchi, Y., Matsunaga, N., Koyanagi, S., Fukagawa, T., Aramaki, H., Higuchi, S., & Ohdo, S. (2005) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0050761 · Cited by 19
Ju, J. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg702 · Cited by 19
Self-citation
Cited by
5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future
Vodenkova, S., Buchler, T., Cervena, K., Veskrnova, V., Vodicka, P., & Vymetalkova, V. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107447 · Cited by 956
Wang, Z., Li, Y., Ahmad, A., Azmi, A. S., Kong, D., Banerjee, S., & Sarkar, F. H. (2010) · Drug Resistance Updates · doi:10.1016/j.drup.2010.07.001 · Cited by 343
Kong, X., Duan, Y., Sang, Y., Li, Y., Zhang, H., Liang, Y., Liu, Y., Zhang, N., & Yang, Q. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27587 · Cited by 290
Lilienthal, I., & Herold, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186885 · Cited by 283
New molecular insights into osteosarcoma targeted therapy
Yang, J., & Zhang, W. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3283622c1b · Cited by 262
Metadata
- Authors
- Song, B., Wang, Y., Titmus, M. A., Botchkina, G., Formentini, A., Kornmann, M., & Ju, J.
- Venue
- Molecular Cancer
- Published
- 2010-04-30
- Volume
- 9
- Issue
- 1
- Pages
- 96-96
- ISSN
- 1476-4598 (ISSN-L)
- OpenAlex
- W2149954427
- Cited by
- 265
- References
- 50
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.